Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: THE GENEVA FOUNDATION
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2012-07-16 to 2023-06-30
Current total value of award: $8999751.37
Description: ADVANCED DEVELOPMENT OF A CANDIDATE COMBINATION DNA VACCINE FOR HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) - CATEGORY A PRIORITY PATHOGENS